Literature DB >> 27038278

Intelligence quotient in paediatric sickle cell disease: a systematic review and meta-analysis.

Jamie M Kawadler1, Jonathan D Clayden1, Chris A Clark1, Fenella J Kirkham1,2.   

Abstract

AIM: Sickle cell disease (SCD) is the commonest cause of childhood stroke worldwide. Magnetic resonance imaging (MRI) is routinely used to detect additional silent cerebral infarction (SCI), as IQ is lower in SCI as well as stroke. This review assesses the effect of infarction on IQ, and specifically whether, compared to healthy controls, IQ differences are seen in children with SCI with no apparent MRI abnormality.
METHOD: A systematic review was conducted to include articles with an SCD paediatric population, MRI information, and Wechsler IQ. A meta-analysis of 19 articles was performed to compare IQ in three groups: stroke vs SCI; SCI vs no SCI; and no SCI vs healthy controls.
RESULTS: Mean differences in IQ between all three groups were significant: stroke patients had lower IQ than patients with SCI by 10 points (six studies); patients with SCI had lower IQ than no patients with SCI by 6 points (17 studies); and no patients with SCI had lower IQ than healthy controls by 7 points (seven studies).
INTERPRETATION: Children with SCD and no apparent MRI abnormality have significantly lower IQ than healthy controls. In this chronic condition, other biological, socioeconomic, and environmental factors must play a significant role in cognition.
© 2016 Mac Keith Press.

Entities:  

Mesh:

Year:  2016        PMID: 27038278     DOI: 10.1111/dmcn.13113

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  17 in total

Review 1.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2017-05-13

2.  Associations of transcranial doppler velocity, age, and gender with cognitive function in children with sickle cell anemia in Nigeria.

Authors:  Kemar V Prussien; Auwal Salihu; Shehu U Abdullahi; Najibah A Galadanci; Khadija Bulama; Raymond O Belonwu; Fenella J Kirkham; Janet Yarboi; Heather Bemis; Michael R DeBaun; Bruce E Compas
Journal:  Child Neuropsychol       Date:  2018-10-01       Impact factor: 2.500

3.  Co-Occurrence of Neurodevelopmental Disorders in Pediatric Sickle Cell Disease.

Authors:  Eboni I Lance; Alicia D Cannon; Bruce K Shapiro; Li-Ching Lee; Michael V Johnston; James F Casella
Journal:  J Dev Behav Pediatr       Date:  2021-08-01       Impact factor: 2.988

Review 4.  Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease.

Authors:  Anna M Hood; Lori E Crosby; Hanne Stotesbury; Melanie Kölbel; Fenella J Kirkham
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

5.  Exploring the relationship of sleep, cognition, and cortisol in sickle cell disease.

Authors:  Melanie Kölbel; Fenella J Kirkham; Ray K Iles; Hanne Stotesbury; Elizabeth Halstead; Celia Brenchley; Sati Sahota; Dagmara Dimitriou
Journal:  Compr Psychoneuroendocrinol       Date:  2022-03-04

6.  Cognitive Function in Sickle Cell Disease Across Domains, Cerebral Infarct Status, and the Lifespan: A Meta-Analysis.

Authors:  Kemar V Prussien; Lori C Jordan; Michael R DeBaun; Bruce E Compas
Journal:  J Pediatr Psychol       Date:  2019-09-01

7.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Catherine Kimber; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2020-04-06

8.  Overnight auto-adjusting continuous airway pressure + standard care compared with standard care alone in the prevention of morbidity in sickle cell disease phase II (POMS2b): study protocol for a randomised controlled trial.

Authors:  Jo Howard; April E Slee; Simon Skene; Baba Inusa; Jamie Kawadler; Michelle Downes; Johanna Gavlak; Melanie Koelbel; Hanne Stotesbury; Maria Chorozoglou; Susan Tebbs; Subarna Chakravorty; Moji Awogbade; David C Rees; Atul Gupta; Patrick B Murphy; Nicholas Hart; Sati Sahota; Carol Nwosu; Maureen Gwam; Dawn Saunders; Vivek Muthurangu; Nathaniel Barber; Emmanuel Ako; Swee Lay Thein; Melanie Marshall; Isabel C Reading; Man Ying Edith Cheng; Fenella J Kirkham; Christina Liossi
Journal:  Trials       Date:  2018-01-22       Impact factor: 2.279

9.  Sickle cell trait and risk of cognitive impairment in African-Americans: The REGARDS cohort.

Authors:  Christina R Cahill; Justin M Leach; Leslie A McClure; Marguerite Ryan Irvin; Neil A Zakai; Rakhi Naik; Frederick Unverzagt; Virginia G Wadley; Hyacinth I Hyacinth; Jennifer Manly; Suzanne E Judd; Cheryl Winkler; Mary Cushman
Journal:  EClinicalMedicine       Date:  2019-05-24

10.  Contrasting resting-state fMRI abnormalities from sickle and non-sickle anemia.

Authors:  Julie Coloigner; Yeun Kim; Adam Bush; Soyoung Choi; Melissa C Balderrama; Thomas D Coates; Sharon H O'Neil; Natasha Lepore; John C Wood
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.